Verition Fund Management
RCUS icon

Verition Fund Management’s Arcus Biosciences RCUS Stock Holding History

Verition Fund Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Buy
+10,000
New +$247K ﹤0.01% 1741
2026
Q1 		– Sell
-21,056
Closed -$502K – 3308
2025
Q4 		$502K Sell
21,056
-23,316
-53% -$476K ﹤0.01% 2654
2025
Q3 		$603K Sell
44,372
-28,937
-39% -$301K ﹤0.01% 2908
2025
Q2 		$597K Buy
73,309
+3,840
+6% +$32.8K ﹤0.01% 2825
2025
Q1 		$545K Buy
69,469
+54,132
+353% +$628K ﹤0.01% 2535
2024
Q4 		$228K Buy
+15,337
New +$250K ﹤0.01% 2923
2024
Q3 		– Sell
-89,611
Closed -$1.36M – 3468
2024
Q2 		$1.36M Buy
+89,611
New +$1.45M 0.01% 1490
2023
Q4 		– Sell
-17,668
Closed -$317K – 2622
2023
Q3 		$317K Buy
+17,668
New +$355K ﹤0.01% 1698
2023
Q2 		– Sell
-357,986
Closed -$6.53M – 2476
2023
Q1 		$6.53M Buy
357,986
+332,146
+1,285% +$6.35M 0.09% 290
2022
Q4 		$534K Buy
25,840
+17,004
+192% +$468K 0.01% 1207
2022
Q3 		$231K Sell
8,836
-141,660
-94% -$3.75M ﹤0.01% 2411
2022
Q2 		$3.81M Buy
+150,496
New +$3.69M 0.08% 359
2022
Q1 		– Sell
-11,455
Closed -$464K – 2974
2021
Q4 		$464K Buy
+11,455
New +$444K ﹤0.01% 1750
2020
Q3 		– Sell
-39,167
Closed -$969K – 1314
2020
Q2 		$969K Sell
39,167
-235,403
-86% -$6.35M 0.03% 422
2020
Q1 		$3.81M Buy
+274,570
New +$3.41M 0.15% 103

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Verition Fund Management's RCUS Position: Q2 2026 in Review

Verition Fund Management opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 10,000 shares worth $308K. The stake represents ﹤0.01% of the portfolio and ranks #1741 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in RCUS as recently as Q4 2025.

Verition Fund Management first reported a position in RCUS in Q1 2020 and has held it in 15 quarters since. The position peaked at $6.53M in Q1 2023. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Verition Fund Management held 10,000 shares of Arcus Biosciences worth $308K as of Q2 2026.
  • Arcus Biosciences was a new Verition Fund Management position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #1741 holding.
  • Verition Fund Management first reported a position in Arcus Biosciences in Q1 2020 and has held it in 15 quarters since.
  • Verition Fund Management's Arcus Biosciences position peaked at $6.53M in Q1 2023.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.